A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
Children's Hospital Medical Center, Cincinnati
Prelude Therapeutics
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
Mayo Clinic
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Therapeutic Advances in Childhood Leukemia Consortium
Advice Pharma Group srl
Pfizer
Stanford University
Rutgers, The State University of New Jersey
Stanford University
Mayo Clinic
Fred Hutchinson Cancer Center
Mayo Clinic
Fred Hutchinson Cancer Center